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The primary objective of this research project is to test the
hypothesis that corticosteroids contribute to the adverse skeletal effects
of space flight. To achieve this objective, serum corticosteroids, which are
known to increase during space flight, must be maintained at normal
physiologic levels in flight rats by a combination of adrenalectomy and
corticosteroid supplementation via implanted hormone pellets. Bone
analyses in these animals will then be compared to those of intact flight
rats that, based on past experience, will undergo corticosteroid excess and
bone loss during space flight. The results will reveal whether
maintaining serum corticosteroids at physiologic levels in flight rats
affects the skeletal abnormalities that normally develop during space
flight. A positive response to this question would indicate that the bone
loss and decreased bone formation associated with space flight are
mediated, at least in part, by corticosteroid excess.
BACKGROUND
Space flight is known to induce alterations in calcium homeostasis.
Gemini, Apollo, and Skylab astronauts exhibited hypercalciuria and
negative calcium balances (1-3). Since the skeleton is the major reservoir
of calcium in the body, increases in the urinary excretion of calcium
presumably reflect bone loss. Photon absorptiometry revealed that the
bone mineral density of the calcaneus declined by approximately 4% in
Skylab crewmembers after 84 days of orbital flight (4). More recently,
bone ultrasound and quantitative computed tomography detected losses
of from 4 to 13% of primarily cancellous bone in the calcaneus and tibia
of a cosmonaut stationed on MIR for 6 months (5). Although it is
commonly assumed that the observed bone loss is due primarily to
increased bone resorption, recent biochemical data indicate that
decreased bone formation may also be involved (5).
Bone histomorphometric analyses are necessary to define more
completely the skeletal effects of space flight. Unfortunately, such
analyses are not feasible in astronauts due to the traumatic nature of the
bone biopsy procedure. For this reason, bone histologic studies in
experimental animals subjected to space flight are of considerable
interest. Rats placed in orbit aboard Soviet Cosmos biosatellites and the
space shuttle exhibited an inhibition of periosteal bone formation (6-8)
and loss of cancellous bone in the long bone metaphysis (9-12). Calcium
kinetic analyses (13) and measurements of the number of osteoclasts (9-
12), the bone resorbing cells, indicate that bone resorption was not
increased in rats during space flight. On the other hand, the number of
osteoblasts, the bone forming cells, was found to be decreased in rats
subjected to space flight (9-12). Therefore, the observed loss of
cancellous bone in flight rats appears to be due primarily to an inhibition
of bone formation rather than a stimulation of bone resorption.
It is commonly assumed that the adverse skeletal effects of space
flight are due to loss of mechanical loading in a weightless environment.
Nevertheless, some lines of evidence suggest that other factors may be
involved. If the bone changes induced by space flight are due solely to
mechanical unloading, these changes should be confined to weightbearing
bones. However, skeletal abnormalities have been detected in bones of
flight rats that lack a weightbearing function such as the maxilla,
mandible, and calvarium (14-16). These findings may be interpreted as
evidence that the skeletal effects of space flight are systemic rather than
confined to weightbearing bones. The failure of on-board centrifugation
to prevent the inhibition of periosteal bone formation in flight rats (17)
also indicates that microgravity is not solely responsible for bone loss
during space flight.
Endocrine factors in general and corticosteroids in particular may
be involved in the etiology of the apparently systemic skeletal effects of
space flight. In support of this concept, plasma cortisol was found to be
significantly increased in Skylab astronauts for the duration of their long-
term missions (1). Several investigators have reported that adrenal
hypertrophy occurred in rats placed in orbit aboard Cosmos biosatellites
(2,3). Exogenous administration of corticosteroids induces marked
hypercalciuria (18) and skeletal alterations that are similar to those
observed during space flight, including cancellous bone loss (19-21),
decreased numbers of osteoblasts (22-24), and an inhibition of periosteal
bone formation (24,25).
In summary, the above findings suggest that the changes in calcium
homeostasis and bone associated with space flight may be mediated, at
least in part, through the action of corticosteroids. This hypothesis has
not been adequately tested to date. The current research project is
designed to manipulate serum corticosteroids by a combination of
adrenalectomy and exogenous supplementation with implanted hormone
pellets. Maintenance of equivalent physiologic levels of serum
corticosteroids in flight and ground-based rats with subsequent bone
analyses will determine whether corticosteroid excess is essential for the
development of skeletal abnormalities during space flight.
ME-HTIODS
The experimental animals were male Sprague Dawley rats that
were 6 weeks of age and weighed an average of 165g at launch. All rats
were anesthetized with an IM injection of ketamine hydrochloride (50
mg/kg body weight) and xylazine (10 mg/kg body weight) and subjected
to bilateral adrenalectomy or sham surgery at 4 days prior to launch. At
the time of surgery, pellets composed of cholesterol with dissolved
corticosterone and aldosterone were implanted in each adrenalectomized
(ADX) rat. The proper doses of the hormones to achieve normal
circulating levels of corticosterone and aldosterone were established in
prior supporting ground-based studies. Each sham-operated rat was
implanted with a placebo cholesterol pellet. On the day before launch, all
rats were injected SC with calcein at a dose of 15 mg/kg body weight to
label bone forming surfaces. Shortly afterwards, six ADX flight rats and
six sham flight rats were loaded in each of two animal enclosure modules
(AEM) and transported to the space shuttle Columbia for launch on
6/20/96 (STS-78). On the day of launch, baseline ADX and sham rats
were sacrificed for collection of serum and bone samples. Other ADX and
sham rats were placed in ground-based AEMs or standard vivarium
(VIV) cages. The experiment therefore consisted of the following 8
groups of rats (N=6/group):
1. Baseline ADX
2. Baseline Sham
3. Flight ADX
4. Flight Sham
5. AEM ADX
6. AEM Sham
7. VlV ADX
8. VlV Sham
After a 17 day space flight, the ADX and sham flight rats were
necropsied between 4 and 6 hours after landing. Serum samples were
collected and stored at -80°C until their corticosterone and aldosterone
concentrations were measured by radioimmunoassay techniques. The
adrenal glands in sham rats were carefully dissected free of adjacent
tissues and weighed with a Mettler balance. Various bones including
both tibiae, femora, lumbar vertebrae, and caudal vertebrae were
stripped of musculature. The left tibia was frozen for subsequent
measurements of bone dry and ash weights. Other bones were placed in
10% phosphate-buffered formalin for 24 hours for tissue fixation. The
bone samples were then dehydrated in increasing concentrations of
ethanol and embedded undecalcified in methyl methacrylate. For
cancellous bone analyses, longitudinal sections were cut at a thickness of
4 _tm with an AO Autocut/Jung 1150 microtome. These sections were
stained according to the Von Kossa method with a tetrachrome
counterstain for measurements of cancellous bone volume (%), osteoclast
surface (%), an index of cancellous bone resorption, and osteoblast surface
(%), an index of cancellous bone formation. All data were collected in
cancellous bone tissue at distances greater than 1 mm from the growth
plate-metaphyseal junction to exclude the primary spongiosa.
The distal half of the right tibia was dehydrated in ethanol and
acetone, then embedded undecalcified in a styrene monomer that
polymerizes into a polyester resin (Tap Plastics, San Jose, CA). The tibial
diaphysis 1-2 mm proximal to the tibiofibular junction was then sawed
into 50-75 _tm thick cross sections with a Buhler Isomet low speed saw.
Cortical bone area, cortical width, and marrow area were measured in
these cross sections. Other measurements include the area of newly
formed bone between the calcein label and the periosteal surface as well
as the distance between the calcein label and the periosteal surface at
100 l_m intervals around the periphery of cortical bone. This distance
was divided by the time interval between administration of the calcein
label and landing (18 days) to calculate periosteal mineral apposition
rate. Similarly, the area of newly formed cortical bone along the
periosteal surface was divided by the same time interval to calculate the
periosteal bone formation rate.
All histomorphometric measurements were performed with the
Bioquant Bone Morphometry System (R&M Biometrics Corp., Nashville,
TN). Data are expressed as the mean for each group + SD. Statistical
differences among groups were evaluated by ANOVA followed by Fisher's
Protected Least Significant Difference (PLSD) test for multiple
comparisons. P values less than 0.05 were considered to be significant.
RESULTS
All rats gained substantial body weight during the course of the
experiment (Figure 1). The ADX and sham flight rats exhibited at least as
much weight gain as the ground-based AEM and VIV rats. In fact, the
mean body weight of the ADX flight group was slightly but significantly
increased compared to the mean body weight of all other groups. These
findings indicate that space flight was well tolerated by the flight rats.
Mean values for adrenal gland weights for the 4 sham groups are
shown in Figure 2. The sham flight group had significantly increased
adrenal gland weights compared to baseline and ground-based AEM and
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VIV sham groups. This finding is consistent with adrenal hypertrophy
and corticosteroid excess in sham flight rats.
Figures 3 and 4 depict mean values for serum corticosterone and
aldosterone, respectively. Sham flight rats exhibited a significantly
higher mean value for serum corticosterone by at least a factor of 2
compared to all other groups. This finding undoubtedly reflects a stress
response to re-entry and postflight handling in these animals. The
ground-based AEM and VIV sham groups also exhibited at least a strong
trend for increased serum corticosterone compared to all 3 ADX groups.
In contrast, the mean value for serum corticosterone remained at 50-60
ng/ml in all ADX groups, which is equivalent to normal physiologic levels
of the hormone in rats. Similarly, mean serum aldosterone (Figure 4) was
maintained at the normal physiologic level of approximately 100 pg/ml
in the 3 ADX groups. Therefore, the implanted hormone pellets were
found to successfully deliver normal levels of corticosterone and
aldosterone to the systemic circulation of ADX rats.
The dry and ash weights of the left tibia (data not shown) were
significantly greater in the flight, AEM, and VIV groups than the baseline
groups due to growth of the former groups during the experimental
period. However, no significant differences in tibial dry and ash weights
were detected among the flight groups (ADX and sham) and the ground-
based AEM and VIV groups (ADX and sham).
Data for cancellous bone volume in the proximal tibial metaphysis
are shown in Figure 5. The mean values were nearly the same for all 8
groups of rats with no significant differences among them. ADX and
sham flight rats also did not exhibit even a trend for decreased cancellous
bone volume in the lumbar vertebra, caudal vertebra, and femoral neck
(data not shown). Similarly, osteoclast surface (Figure 6), an index of
bone resorption, and osteoblast surface (Figure 7), an index of bone
formation, varied little in the proximal tibial metaphysis of all groups.
These cellular variables also did not differ in the lumbar and caudal
vertebrae of flight rats (ADX and sham) compared to the ground-based
AEM and VIV rats (data not shown).
Structural data for cortical bone in the tibial diaphysis are shown in
Figures 8-10. A growth-related increase in cortical bone area and width
was detected in the older flight, AEM, and VIV groups compared to the
younger baseline groups. However, when comparing rats of the same
age, these variables did not differ in the flight groups (ADX and sham)
compared to the AEM and VIV groups. Marrow area was nearly the
same in all 8 groups of rats.
Age-related decreases in periosteal bone formation rate (Figure 11)
and periosteal mineral apposition rate (Figure 12) occurred in the flight,
AEM, and VIV groups compared to the baseline groups. However, the
mean values for these variables were very similar in the flight groups
(ADX and sham) compared to the ground-based AEM and VIV groups.
CONCLUSIONS
All preflight procedures were accomplished as planned. The rats
were successfully adrenalectomized (ADX) and the implanted hormone
pellets delivered physiologic levels of corticosterone and aldosterone to
the systemic circulation. The substantial increase in body weight that
occurred in all rats indicated that the ADX/supplemented rats were
healthy and that the flight rats tolerated space flight well. The observed
adrenal hypertrophy in the intact sham flight rats was also a positive
finding in that it was suggestive of corticosteroid excess in these animals.
Unfortunately, the experimental objective, which was to test the
hypothesis that corticosteroids contribute to bone loss during space flight,
could not be achieved due to lack of bone changes in intact flight rats.
These animals exhibited normal cancellous bone mass at several different
skeletal sites. Furthermore, both cancellous and cortical bone formation
were found to be normal in flight rats compared to ground-based control
rats. The results clearly indicate that space flight has minimal effects on
bone mass and bone formation in rapidly growing rats. This finding is
surprising in view of previous reports of cancellous bone loss (9-12) and
an inhibition of bone formation (6-12) in rats subjected to space flight.
However, it is important to note that the rats from most of these previous
studies were older than the rats from the current study. In addition, the
former rats were often housed singly while in space compared to the
group housing for the animals of our experiment. Finally, the strain of
the rats also varied among the different flight experiments. Therefore,
the negative findings of the current study emphasize the importance of
rat age, strain, and housing conditions for the development of bone
changes during space flight. These factors are crucially important for the
planning of future experiments involving use of rats as an animal model
for the adverse skeletal effects of space flight.
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NON-TECHNICAL SUMMARY
Corticosteroid hormones that are secreted by the adrenal glands in
response to stressful situations are known to be increased during space
flight. These hormones are also known to have adverse effects on bone.
Therefore, the experiment was designed to determine whether excess
secretion of corticosteroid hormones by the adrenal glands contributes to
the bone loss associated with space flight. A certain group of flight rats
had their adrenal glands removed surgically, but were then
supplemented with normal levels of corticosteroids by implanted
hormone pellets. Another group of flight rats with intact adrenal glands
would presumably experience corticosteroid excess. A comparison of
bone between these groups would reveal whether maintaining
corticosteroids at normal levels in flight rats affects the bone changes
that occur during space flight. Although the planned hormonal
manipulations were successful, the experimental objective could not be
achieved due to lack of the expected bone changes in flight rats with
intact adrenal glands. These animals had normal amounts of bone mass
and normal levels of bone formation compared to ground-based control
rats. Therefore, space flight was found to have minimal effects on bone
mass and bone formation in rapidly growing rats. This negative result
may be a consequence of rapid bone growth in young rats, strain of rat,
and/or group housing conditions during space flight. Therefore, the
findings emphasize the importance of rat age, strain, and housing for the
planning of future space flight experiments.
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